EORTC Groups Annual Meeting (EGAM) - EORTC

More information on the conference website.

Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ – The LORD study - ScienceDirect

EORTC Guidelines 2017, PDF, Radiation Therapy

Early Career Investigators Program: Structure and benefits - ecancer

Early detection of oligometastatic disease

Classification of breast tumours into molecular apocrine, luminal and basal groups based on an explicit biological model

Medflixs - EORTIC Groups Annual Meeting (EGAM) 2019

32nd EORTC-NCI-AACR Symposium - EORTC

Medflixs - EORTIC Groups Annual Meeting (EGAM) 2019

PPT - EORTC STBSG PowerPoint Presentation, free download - ID:177808

Multidisciplinary Approach to Lung Cancer Care

Discovery of RMC-5552, a Selective Bi-Steric Inhibitor of mTORC1, for the Treatment of mTORC1-Activated Tumors

Classification of breast tumours into molecular apocrine, luminal and basal groups based on an explicit biological model

organisation current research and strategies 2011 - 2012 - eortc

EORTC Groups Annual Meeting (EGAM) 2019 - ecancer